Pacer Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-21,366
Closed -$3.56M 1269
2018
Q2
$3.56M Buy
+21,366
New +$3.43M 0.16% 109
2017
Q3
Sell
-7,766
Closed -$1.89M 1273
2017
Q2
$1.89M Buy
+7,766
New +$1.82M 0.19% 75
2016
Q3
Sell
-8,179
Closed -$1.89M 1093
2016
Q2
$1.89M Buy
8,179
+782
+11% +$180K 0.3% 53
2016
Q1
$1.98M Buy
+7,397
New +$2.12M 0.45% 48
2013
Q4
$237K Buy
+921
New +$144K 0.06% 433

Other funds holding AGN

Pacer Advisors's AGN Position: Q3 2018 in Review

Pacer Advisors sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 21,366 shares — an estimated $3.56M sold.

Pacer Advisors first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $3.56M in Q2 2018. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Pacer Advisors reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Pacer Advisors sold 21,366 Allergan plc shares in Q3 2018, an estimated $3.56M.
  • Pacer Advisors first reported a position in Allergan plc in Q4 2013 and held it in 5 quarters.
  • Pacer Advisors's Allergan plc position peaked at $3.56M in Q2 2018.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.